Press release
Paracetamol IV Market worth $1,575.45 million by 2030, growing at a CAGR of 7.64% - Exclusive Report by 360iResearch
The "Paracetamol IV Market by Indication (Pain, Pyrexia/Fever), Application (Non-surgical, Surgical), End-use - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/paracetamol-iv?utm_source=openpr&utm_medium=referral&utm_campaign=sample
Paracetamol intravenous (IV) solutions, known as acetaminophen IV, are essential for treating pain and fever in scenarios where oral administration is not possible. This makes it vital in medical settings such as surgical environments, emergency care, and for patients unable to ingest medications orally. End-users primarily include hospitals, ambulatory surgical centers, and emergency departments. The market's growth is fueled by factors such as an increasing number of surgical procedures, rising awareness of the non-opioid pain relief efficacy and safety of Paracetamol IV, and promising regulatory approvals. Emerging markets with developing healthcare infrastructures present significant opportunities. Additionally, investing in technological advancements and forming partnerships with healthcare institutions can improve delivery systems and enhance patient compliance. However, the market faces challenges, including higher costs compared to oral formulations, potential side effects, and stringent regulations that necessitate rigorous clinical trials. Innovation and research can drive growth by focusing on enhanced formulations to minimize side effects, exploring alternative delivery systems, and creating patient-centric solutions, such as smart infusion pumps or single-dose options. The market is competitive and dynamic, requiring continual innovation and a deep understanding of evolving patient needs to stay ahead. Addressing unmet needs through innovative solutions offers the potential for sustainable growth and improved market positioning. By leveraging growth factors and strategically tackling challenges, businesses can effectively capture the market potential.
Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/paracetamol-iv?utm_source=openpr&utm_medium=referral&utm_campaign=inquire
Market Segmentation & Coverage:
This research report categorizes the Paracetamol IV Market in order to forecast the revenues and analyze trends in each of following sub-markets:
Based on Indication, market is studied across Pain and Pyrexia/Fever.
Based on Application, market is studied across Non-surgical and Surgical.
Based on End-use, market is studied across Clinics and Hospitals.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Key Company Profiles:
The report delves into recent significant developments in the Paracetamol IV Market, highlighting leading vendors and their innovative profiles. These include Aurobindo Pharma Ltd., Biological E. Limited, Cfl Pharmaceuticals Limited, Changshu Huagang Pharmaceuticals Co., Ltd., Dr. Reddy's Laboratories Ltd., Geno Pharmaceuticals Private Limited, Hebei Jiheng Pharmaceutical Co.,Ltd., Huzhou Konch Pharmaceutical Co., Ltd., Lupin Pharmaceuticals, Inc., Mallinckrodt PLC, Novartis AG, Sanofi S.A., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., and Zhejiang Kangle Pharmaceutical Co., Ltd..
Introducing ThinkMi Query: Revolutionizing Market Intelligence with AI-Powered Insights for the Paracetamol IV Market
We proudly unveil ThinkMi Query, a cutting-edge AI product designed to transform how businesses interact with the Paracetamol IV Market. ThinkMi Query stands out as your premier market intelligence partner, delivering unparalleled insights with the power of artificial intelligence. Whether deciphering market trends or offering actionable intelligence, ThinkMi Query is engineered to provide precise, relevant answers to your most critical business questions. This revolutionary tool is more than just an information source; it's a strategic asset that empowers your decision-making with up-to-the-minute data, ensuring you stay ahead in the fiercely competitive Paracetamol IV Market. Embrace the future of market analysis with ThinkMi Query, where informed decisions lead to remarkable growth.
Ask Question to ThinkMi Query @ https://www.360iresearch.com/library/intelligence/paracetamol-iv?utm_source=openpr&utm_medium=referral&utm_campaign=query
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Paracetamol IV Market, by Indication
7. Paracetamol IV Market, by Application
8. Paracetamol IV Market, by End-use
9. Americas Paracetamol IV Market
10. Asia-Pacific Paracetamol IV Market
11. Europe, Middle East & Africa Paracetamol IV Market
12. Competitive Landscape
13. Competitive Portfolio
Read More @ https://www.360iresearch.com/library/intelligence/paracetamol-iv?utm_source=openpr&utm_medium=referral&utm_campaign=analyst
Contact 360iResearch
Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550
About 360iResearch
360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Paracetamol IV Market worth $1,575.45 million by 2030, growing at a CAGR of 7.64% - Exclusive Report by 360iResearch here
News-ID: 3567998 • Views: …
More Releases from 360iResearch

Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Globa …
In recent years, the silent ascent of human metapneumovirus (HMPV) infections has begun to capture significant attention within the realm of infectious diseases. As we advance in medical science, unraveling complexities of age-old pathogens like common influenza or emerging illnesses like COVID-19, a critical discourse has been emerging around HMPV. Particularly, there seems to be a burgeoning acknowledgment of its growing impact on vulnerable global populations, propelling an increased demand…

The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and …
From Appetite to Advocacy: The Rising Demand for Meat Alternatives
In recent years, the global food industry has been undergoing a remarkable transformation, driven primarily by an increasing consumer demand for healthier, sustainable, and ethically sourced food products. This seismic shift has brought traditional meat alternatives and high-protein plant-based foods into the spotlight. As the world becomes more conscious of the implications of meat consumption on health and the environment, the…

The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 202 …
Unpacking the Surge in Investments and Collaborations to Bolster Mobility-as-a-Service
In recent years, as urban landscapes continually evolve, a transformative shift known as Mobility-as-a-Service (MaaS) has reshaped the way we perceive transportation. Marked by the integration of various forms of transport services into a single accessible on-demand mobility solution, MaaS is rapidly gaining traction across global cities. As an emerging paradigm, it's not just shaping the future of travel but also…

The Data Center Services Market size was estimated at USD 56.65 billion in 2023 …
Smart City Revolutions: Why Data Center Colocation is the Future Backbone
In the era of digital transformation, urban landscapes across the globe are undergoing a seismic shift toward becoming "smart cities." The concept of a smart city revolves around using digital technology, IoT (Internet of Things), AI, and data analytics at an unprecedented scale to improve urban infrastructure, manage resources efficiently, and enhance the quality of life for citizens. A vital…
More Releases for Paracetamol
Paracetamol Granule Market Outlook and Future Projections for 2030
The paracetamol granule market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines the current…
Paracetamol Market Research Report 2023 | Valuates Reports
Paracetamol Market
Paracetamol, also named acetaminophen, is an active ingredient in hundreds of over-the-counter (OTC) and prescription medicines. It relieves pain and fever. And, it is also combined with other active ingredients in medicines that treat allergy, cough, colds, flu, and sleeplessness.
Download Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-30W8975/Global_Paracetamol_Market_Insights_and_Forecast_to_2028
Due to the COVID-19 pandemic, the global Paracetamol market size is estimated to be worth US$ 127 million in 2022 and is forecast to a readjusted size…
Paracetamol Market: multiple applications of paracetamol in health relief drive …
Pune 15 Feb 2023: The "Paracetamol Market" was USD 1.56 bn in 2021 and is expected to grow at a CAGR 4.4 percent to reach USD 2.20 bn by 2029 during the forecast period. Paracetamol Market report is published by Maximize Market Research available in the market. It has multiple clients in the healthcare segment in more than 34 countries.
Paracetamol Market Scope and Research Methodology
The report includes industry facets along…
Paracetamol Price, Historical Charts, Forecasts & News
Product Name - Paracetamol
HS Code - 29222933
Molecular Weight - 151.16 g/mol
Chemical Formula - HOC6H4NHCOCH3
Synonyms - 4-Acetamidophenol, 103-90-2 ,
N-(4-Hydroxyphenyl)acetamide
Currency - US$ (Data can also be provided in local currency)
Supplier Database Availability - Yes
Customization Scope - Our services can be customized as per the requirements of the customer
Post-Sale Analyst Support - 360-degree analyst support after service delivery
Region/Countries for which Data is available
Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Iran,…
Acetaminophen (paracetamol) Market Shares, Strategies, and Forecasts Analysis
Acetaminophen, commonly known as Paracetamol is the most widely used analgesic and antipyretic that relieves pain and reduce fever. Discovered in 1877, the drug is typically used for mild to moderate pain. It is prescribed either alone with or in a combination with cold medication. The name ‘Paracetamol’ is approved by the International Nonproprietary, Australia and Britain, while Acetaminophen is the name that is approved and used in U.S and…
Paracetamol Market - Changing Supply And Demand Scenarios By 2025
A detailed market study on "Global Paracetamol Market" examines the performance of the Paracetamol market. It encloses an in-depth Research of the Paracetamol market state and the competitive landscape globally. This report analyzes the potential of Paracetamol market in the present and the future prospects from various angles in detail.
The Global Paracetamol Market 2018 report includes Paracetamol market Size, Revenue, market Share, Paracetamol industry volume, market Trends, Paracetamol Growth aspects.…